Trade Summary

1 month ago, Ecor1 Capital, LLC, serving as Dir at Aktis Oncology, Inc. (AKTS), purchased 2,222,222 shares at $18.00 per share, for a total transaction value of $39,999,996.00. Following this transaction, Ecor1 Capital, LLC now holds 347,305 shares of AKTS.

This purchase represents a 119.00% decrease in Ecor1 Capital, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 12, 2026, meaning the disclosure happened on the same day as the trade.